key: cord-0827313-uf6kad8j
authors: Wongtangman, Karuna; Eikermann, Matthias
title: The authors reply
date: 2021-07-13
journal: Crit Care Med
DOI: 10.1097/ccm.0000000000005218
sha: cd1c88ff3cdcda61cf7fde8aa0ee97117e166b5d
doc_id: 827313
cord_uid: uf6kad8j

nan

W e appreciate the comments by Xiao and Zhao (1) on our newly article published recently in Critical Care Medicine (2) . Our group and others reported that patients with coronavirus disease 2019 (COVID-19)-induced acute respiratory distress syndrome (ARDS) received higher doses of hypnotics than patients with ARDS of other etiologies and experienced higher acute brain dysfunction (3, 4) . Our study (2) adds the important information that overuse of sedatives increases the risk of prolonged coma, which increases the vulnerability to a fatal outcome.

Xiao and Zhao (1) speculate around possible reasons of the overuse of sedatives in patients with COVID-19-induced ARDS, and we agree with these thoughts: ICU providers may have been overfocused on the goal of preventing self-extubation and the associated risk of virus transmission to providers in an overburdened healthcare system. During the pandemic, often one nurse was responsible for numerous COVID-19 patients, and personal protective equipment may have not been available without restrictions. Continuous infusions of sedative medications were preferred in these circumstances, which made titration to light sedation very challenging. In addition, short-acting sedatives were not always available, such that long-acting benzodiazepines were used.

In our study (2) , we ensured that differences in case acuity did not bias our conclusions. There were no differences between patients with and without COVID-19 in Pao 2 :Fio 2 ratio, minute ventilation, pH, Sequential Organ Failure Assessment scores, or brain pathology. Thus, those differences in cases severity did not explain the overuse of sedative medications and the higher percentage of coma in patients with COVID-19, which we found mediated an increase in in-hospital mortality.

Our study (2) emphasizes the importance of avoiding prolonged, deep sedation. A light sedation goal in mechanically ventilated critically ill patients with ARDS decreases the risk of prolonged coma and helps decrease in-hospital mortality in patients with severe ARDS.

Reasons for the Overuse of Sedatives and Deep Sedation for Mechanically Ventilated Coronavirus Disease

Association of sedation, coma, and in-hospital mortality in mechanically ventilated patients with coronavirus disease 2019-related acute respiratory distress syndrome: A retrospective cohort study

Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): A multicentre cohort study

In response: The use of analgesia and sedation in mechanically ventilated patients with COVID-19

Coagulopathy in COVID-19

Prevalence of thrombotic complications in ICUtreated patients with coronavirus disease 2019 detected with systematic CT scanning

To the Editor: C oronavirus disease 2019 is associated with coagulopathy (1). We read with interest the study of Mirsadraee et al (2) published in the recent issue of Critical Care Medicine, who demonstrated that thrombotic complications are frequently observed in critically ill patients with severe coronavirus disease 2019 hospitalized in the ICU by performing routine image surveillances. Several concerns have been raised.The authors could not find any baseline characteristics including coagulopathyrelated biomarkers that predicted thrombotic complications (2) . In their definition, all thrombotic complications were counted as end points. How about investigating factors associating with severe or fatal thrombotic complications, instead of all thrombotic complications? They should be the end point that we want to predict.In their study, the patients with thrombotic complications had a higher prevalence of mortality (2) . The next concern is causality: whether the thrombotic complications themselves were directly associated with death or the severity of coronavirus disease 2019 and comorbidities were associated with death (1). Causes of death and multivariate analyses adjusting for baseline characteristics would approach this concern. Several patients seem to have received repeated image assessments (2) . Additional analyses to investigate the prognostic impact of improvement in thrombotic complications would clarify the implication of aggressive intervention to the thrombotic complications.

Dr. Imamura receives grant support from Japan Society for the Promotion of Science KAKENHI: JP20K17143.